Sachem Capital Corp. 7.75% Notes due 2025 Stock (AMEX: SCCC)

Latest News for Sachem Capital Corp. 7.75% Notes due 2025 Stock (AMEX:SCCC)

Sachem Capital Corp. 7.75% Notes due 2025

TFI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) reported quarterly earnings of $1.24 per share which missed the analyst consensus estimate of $1.36 by 8.82 percent. This is a 6.77 percent decrease over earnings of $1.33 per share from the same period last year. The company reported quarterly sales of $1.87 billion which missed the analyst consensus estimate of $1.90 billion by 1.33 percent. This is a 1.11 percent increase over sales of $1.85 billion the same period last year.

Earnings

Earnings Misses

News

TFII

TFI International Q1 EPS $1.24 Misses $1.36 Estimate, Sales $1.87B Miss $1.90B Estimate

WIIM

TEAM

Atlassian shares are trading lower. The company reported Q3 financial results.

Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares are trading lower after the company reported worse-than-expected first-quarter sales results and issued earnings guidance below estimates on Thursday. Here's a <a href="https://www.benzinga.com/pressreleases/24/04/b38443217/intel-reports-first-quarter-2024-financial-results">look at the details. </a>
The Details:
Intel reported quarterly earnings of 18 cents per share, which beat the analyst consensus estimate of 14 cents by 28.57%. 
Quarterly sales came in at $12.72 billion, which missed the analyst consensus estimate of $12.78 billion by 0.44% and represents an 8.61% increase over sales of $11.71 billion from the same period last year.
Revenue by segment in the first quarter and the year-over-year change was:
<figure class="wp-block-table is-style-regular"> 
<table>
<tbody>
<tr>
<td>Client Computing Group (CCG)</td>
<td>&nbsp;</td>
<td>$7.5 billion</td>
<td>&nbsp;</td>
<td>up</td>
<td></td>
<td>31%</td>
</tr>
<tr>
<td>Data Center and AI (DCAI)</td>
<td>&nbsp;</td>
<td>$3.0 billion</td>
<td>&nbsp;</td>
<td>up</td>
<td></td>
<td>5%</td>
</tr>
<tr>
<td>Network and Edge (NEX)</td>
<td>&nbsp;</td>
<td>$1.4 billion</td>
<td>&nbsp;</td>
<td>down</td>
<td></td>
<td>8%</td>
</tr>
<tr>
<td>Intel Foundry</td>
<td>&nbsp;</td>
<td>$4.4 billion</td>
<td>&nbsp;</td>
<td>down</td>
<td></td>
<td>10%</td>
</tr>
</tbody>
</table>
</figure>
&#8220;We are making steady progress against our priorities and delivered a solid quarter,&#8221; said Pat Gelsinger, Intel CEO.&nbsp;
&#8220;Strong innovation across our client, edge and data center portfolios drove double-digit revenue growth in Intel Products. With Intel 3 in high-volume production, leading-edge semiconductors are being manufactured in the U.S. for the first time in almost a decade and we are on track to regain process leadership next year as we grow Intel Foundry,&#8221; he added.
&#8220;We are confident in our plans to drive sequential growth throughout the year as we accelerate our AI solutions and maintain our relentless focus on execution, operational discipline and shareholder value creation in a dynamic market,&#8221; Gelsinger said. 
Outlook:&nbsp;
Intel sees second-quarter earnings of 10 cents per share, versus the 10 cent estimate, and revenue in a range of $12.5 billion to $13.5 billion, versus the $12.68 billion estimate.&nbsp;
Related News: <a href="https://www.benzinga.com/news/earnings/24/04/38441140/s-p-global-reports-q1-results-raises-revenue-guidance">S&amp;P Global Reports Q1 Results, Raises Revenue Guidance</a>
INTC Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Intel shares are down 8.7% after-hours at $31.96 at the time of publication Thursday.
Image: Monticello from Shutterstock

Movers

INTC

Intel Shares Fall On Q1 Revenue Miss, Weak Q2 EPS Guidance

Guidance

Skechers Raises FY24 Sales Outlook From $8.60B-$8.80B To $8.725B-$8.875B (Est $8.781B), EPS From $3.65-$3.85 To $3.95-$4.10 (Est $3.90)

Columbia Banking System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.53 by 22.64 percent. This is a 41.3 percent increase over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $473.719 million which missed the analyst consensus estimate of $480.364 million by 1.38 percent. This is a 10.31 percent increase over sales of $429.433 million the same period last year.

Earnings Beats

COLB

Columbia Banking System Q1 2024 Adj EPS $0.65 Beats $0.53 Estimate, Sales $473.719M Miss $480.364M Estimate

GILD

Gilead Sciences shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

Dividends

Comfort Systems Raises Dividend From $0.25 To $0.30

GOOG

GOOGL

Alphabet Board Initiated Cash Dividend Program, Declared Dividend Of $0.20/Share

VINC

Vincerx Pharma shares are trading lower after the company announced a proposed underwritten public offering of common stock and warrants.

LivaNova PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVN#NASDAQ">LIVN</a>), a market-leading medical technology company, today announced that its wholly-owned U.S. subsidiary, LivaNova USA, Inc., is providing notice to U.S. patients regarding a cybersecurity incident that was initially disclosed by the Company on November 20, 2023.
The incident resulted in a disruption to portions of the Company's information technology systems. Promptly after detecting the issue on November 19, 2023, LivaNova began an investigation with assistance from external cybersecurity experts and coordinated with law enforcement. The Company took action to remediate the issue, such as taking certain systems offline, and resumed manufacturing as previously disclosed. In the course of its investigation, the Company determined that its systems were first accessed by an unauthorized party around October 26, 2023.
On April 10, 2024, LivaNova learned that the unauthorized party obtained certain identifiable personal information of U.S. patients. While the Company is continuing to analyze the nature and scope of the affected information, the Company is aware that the information, which varied by impacted individual, included data such as name, contact information (e.g., phone number, email and postal address), Social Security number, date of birth, medical information (e.g., treatment, condition, diagnosis, prescription, physician, medical record number and device serial number), and health insurance information.
On April 25, 2024, LivaNova posted notice of this incident on its website. The Company is sending notice to affected U.S. patients for whom it has contact information. The Company's notice of this incident includes information on how affected U.S. patients can enroll in complimentary identity protection and credit monitoring services. LivaNova encourages affected patients in the U.S. to remain vigilant for incidents of fraud and identity theft by reviewing their account statements and monitoring their free credit reports, and to remain alert for unsolicited communications involving personal information.
Affected U.S. patients who have questions or would like additional information about this issue can contact (833) 931-5100 toll-free, Monday through Friday, 8 a.m. to 8 p.m. CT (excluding major U.S. holidays). Please reference engagement number B121304 when calling. Additional information is available at<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.livanova.com&amp;esheet=53957159&amp;newsitemid=20240425016136&amp;lan=en-US&amp;anchor=www.livanova.com&amp;index=1&amp;md5=ed7e6d50fccbd2788b2c725efc7b38da">www.livanova.com</a>.

LIVN

LivaNova Issues Notice To U.S. Patients Regarding Cybersecurity Incident Initially Disclosed By The Company On November 20, 2023

Orchid Island Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORC#NYSE">ORC</a>) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.09) by 33.33 percent. The company reported quarterly sales of $(2.490 million) which beat the analyst consensus estimate of $(3.227 million) by 22.84 percent. This is a 40.78 percent increase over sales of $(4.205 million) the same period last year.

Orchid Island Cap Q1 2024 Adj EPS $(0.12) Misses $(0.09) Estimate, Sales $(2.490M) Beat $(3.227M) Estimate

Boston Beer Co Sees FY24 GAAP EPS $7.00-$11.00 Vs $9.91 Est.

Vincerx Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) today announced a proposed underwritten public offering of shares of its common stock and accompanying common stock warrants to purchase shares of its common stock and, to certain investors, pre-funded warrants to purchase shares of common stock and accompanying common stock warrants to purchase shares of its common stock. All of the shares, pre-funded warrants and common stock warrants in the proposed offering will be offered by Vincerx. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. &nbsp;
Leerink Partners is acting as the sole bookrunning manager for the offering.

Offerings

Vincerx Pharma Announces Proposed Underwritten Public Offering Of Common Stock And Warrants; No Size Or Amount Disclosed

Legal

JOANQ

Joann Gets Court Approval For Prepackaged Recapitalization Plan

Cousins Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUZ#NYSE">CUZ</a>) reported quarterly FFO of $0.65 per share which beat the analyst consensus estimate of $0.64 by 1.56 percent. The company reported quarterly sales of $209.241 million which beat the analyst consensus estimate of $199.473 million by 4.90 percent. This is a 3.21 percent increase over sales of $202.728 million the same period last year.

Cousins Props Q1 2024 FFO $0.65 Beats $0.64 Estimate, Sales $209.241M Beat $199.473M Estimate

Edwards Lifesciences Sees FY24 Adj. EPS $2.70-$2.80 Vs $2.76 Est.; Revenue $6.3B-$6.6B Vs $6.516B Est.

AvalonBay Communities Sees Q2 Core FFO $2.63-$2.73; FY24 Core FFO $10.71-$11.11

Principal Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) reported quarterly earnings of $1.65 per share which missed the analyst consensus estimate of $1.73 by 4.62 percent.

Principal Finl Gr Q1 2024 Adj EPS $1.65 Misses $1.73 Estimate

Gaming and Leisure Props (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLPI#NASDAQ">GLPI</a>) reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $0.93 by 1.08 percent. This is unchanged from the same period last year. The company reported quarterly sales of $375.96 million which beat the analyst consensus estimate of $370.54 million by 1.46 percent. This is a 5.84 percent increase over sales of $355.21 million the same period last year.

GLPI

Gaming and Leisure Props Q1 FFO $0.92 Misses $0.93 Estimate, Sales $375.96M Beat $370.54M Estimate

Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) reported quarterly earnings of $3.13 per share which missed the analyst consensus estimate of $3.41 by 8.21 percent. The company reported quarterly sales of $3.22 billion which beat the analyst consensus estimate of $3.18 billion by 1.16 percent. This is a 18.92 percent increase over sales of $2.71 billion the same period last year.

Arthur J. Gallagher Q1 2024 Adj EPS $3.13 Misses $3.41 Estimate, Sales $3.22B Beat $3.18B Estimate

Sachem Capital Corp. (SACH) Q1 2023 Earnings Call Transcript

A Wall Of Worry

Mortgage REITs: High-Yield Risk And Opportunity

Sachem Capital Corp. (SACH) Q2 2023 Earnings Call Transcript

Earnings Can't Cure Gloom

Sachem Capital Corp. (SACH) Q3 2023 Earnings Call Transcript

Sachem Capital: Fed About To Pivot, Fat 12.4% Yield Not Yet In Play

Sachem Capital: I Am Sticking With The 9% Yielding Baby Bonds

Sachem Capital Corp. (SACH) Q4 2023 Earnings Call Transcript

Sachem Capital: Avoid The 12% Common Dividend Yield For The Bonds

AAIC

AAIN

ACRE

AFCG

AGNC

AGNCL

AGNCM

AGNCN

AGNCO

AGNCP

AJXA

AOMR

BALY

BCEFF

BCEPF

BCEXF

BCPPF

BECEF

BLDG

BRSP

BXMT

CHMI

CMBS

CNTY

CUBE

EARN

EPRT

EQIX

ESRT

EWRE

FBRT

FREL

GPMT

GQRE

HASI

HAUS

HAUZ

HOMZ

IFGL

INDS

INVH

KBWY

KREF

LADR

MITT

MORT

NAIL

NETL

NREF

NTST

NURE

NYMT

NYMTL

NYMTM

NYMTN

NYMTZ

PFFR

PLDGP

PMTU

PPTY

RDOG

REET

REFI

REGCO

REGCP

REIT

RESI

RIET

RITM

ROIC

ROOF

SACC

SACH

SBAC

SCCB

SCCC

SCCD

SCCE

SCCF

SCCG

SCHH

SEVN

SRVR

STAG

STWD

TRTX

USRT

VICI

VIOO

VRAI

WELL

XLRE

7.75% NT REDEEM 30/09/2025 USD 25 - 78590A406